DELL
PYPL
CVS

David W. Dorman

Known title: DirectorCIK: 0001082870

David W. Dorman's purchase track record

David W. Dorman has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
2/8/2022PYPL$1.00M-34.5%-21.4%
11/23/2021PYPL$288K-45.1%-58.2%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Michael Dell warns memory shortage could last four years. Michael Dell stated that the current memory shortage might persist for four years, highlighting a significant supply chain challenge for the company. This warning coincides with recent sector-wide selling, where Dell stock dropped 3% amid broader hardware concerns. The news underscores the operational risks Dell faces in its transition to AI infrastructure, adding context to its recent price volatility.

this person other insiders at DELL

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

PayPal (PYPL) launches AI-powered checkout with Glance. PayPal announced an AI-driven shopping and checkout experience in partnership with Glance, bringing the technology to tens of millions of U.S. consumers. The rollout is described as the company's first major AI commerce initiative and is expected to enhance merchant and buyer interactions. Recent coverage notes that PayPal outperformed the broader market and that Bank of America has resumed payments sector coverage, highlighting renewed analyst focus on the firm.

this person other insiders at PYPL

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.

this person other insiders at CVS

Transaction History

DELL▼ Sell$0
DELL▲ Buy$0
DELL▼ Sell$8.4M
DELL▼ Sell$5.6M
DELL▼ Sell$1.7M
DELL▼ Sell$1.0M
PYPL▲ Buy$0
PYPL▲ Buy$0
PYPL▲ Buy$0
PYPL▲ Buy$0
DELL▲ Buy$0
PYPL▲ Buy$0
PYPL▲ Buy$0
PYPL▲ Buy$0
DELL▲ Buy$0
DELL▼ Sell$10.1M
PYPL▲ Buy$0
PYPL▲ Buy$0
DELL▲ Buy$0
PYPL▲ Buy$0
PYPL▲ Buy$0
DELL▲ Buy$0
PYPL▲ Buy$0
CVS▲ Buy$5K
PYPL▲ Buy$1.0M
PYPL▲ Buy$0
DELL▲ Buy$0
PYPL▲ Buy$92K
PYPL▲ Buy$113K
PYPL▲ Buy$28K
PYPL▲ Buy$13K
PYPL▲ Buy$42K
CVS▲ Buy$292K
DELL▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.